Results 1 to 10 of about 13,254 (218)

In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa

Frontiers in Pharmacology, 2020
ObjectiveDrawing a growth curve of multidrug-resistant Pseudomonas aeruginosa (MDR-PA) provides a foundation for susceptibility testing. By observing in vitro antibacterial activity and ultrastructure cthanges on MDR-PA of the effective components in the
Hongri Xu, Chang Liu, Meng Li, Chengxiang Wang, Guoxing Liu, Honghong Wang, Jie Ma, Lei Li, Meng Chen, Miao Cheng, Xingwei Yao, Ying Lin, Shitong Zhao, Yuting Wang, Mingzhe Wang   +14 more
doaj   +1 more source

Randomized Comparison of Piperacillin/Tazobactam Versus Imipenem/Cilastatin in the Treatment of Patients with Intra-abdominal Infection

Asian Journal of Surgery, 2004
Treatment of intra-abdominal infections remains a challenge because of their polymicrobial nature and associated mortality risk. Broad-spectrum empiric coverage is usually required.
Alex A. Erasmo
doaj   +1 more source

Drug–laboratory interaction between beta-lactam antibiotics and the galactomannan antigen test used to detect mould infections

Brazilian Journal of Infectious Diseases, 2014
Several studies have demonstrated that piperacillin/tazobactam produces a false-positive result for the galactomannan antigen test. However, the most recent literature has demonstrated that this interaction is no longer a concern.
Kristin A. Otting, Kayla R. Stover, John D. Cleary   +2 more
doaj   +1 more source

Mycobacterium abscessus skin and soft tissue infection following autologous fat grafting in Kurdistan treated with an antibiotic combination including Imipenem-Relebactam and Rifabutin

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023
Medical tourism is becoming increasingly popular. The most popularly sought operations are cosmetic procedures. With the increase in cosmetic tourism, it is unsurprising that there has also been a rise in skin and soft tissue infections caused by ...
Alison J. Beech, Sharon E. Weinberg, Alice E. Mortimer, Fiona Lynch, James Bedford, Giorgio Calisti   +5 more
doaj   +1 more source

Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity

Journal of Lipid Research, 2018
Nephrotoxicity is a major limitation to cisplatin antitumor therapies. Cilastatin, an inhibitor of renal dehydropeptidase-I, was recently proposed as a promising nephroprotector against cisplatin toxicity, preventing apoptotic cell death.
Estefanía Moreno-Gordaliza, Diego Esteban-Fernández, Alberto Lázaro, Sarah Aboulmagd, Blanca Humanes, Alberto Tejedor, Michael W. Linscheid, M. Milagros Gómez-Gómez   +7 more
doaj   +1 more source

Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China

Frontiers in Pharmacology, 2022
Background: Tigecycline was recently found to cause coagulation disorders, especially hypofibrinogenemia, which may interfere with the administration of antimicrobial therapy.
Bing Leng, Chengwu Shen, Tiantian Gao, Kai Zhao, Xuemei Zhao, Yujin Guo, Jiyong Wu, Jing Yang, Wei Fang, Jicheng Zhang, Yahui Zhang, Chao Sun, Lei Duan, Jing Huang, Yougang Qi, Genquan Yan   +15 more
doaj   +1 more source

Successful treatment of multiple microbleeds in a large area of the small bowel by transcatheter arterial embolization using imipenem/cilastatin as embolization material

Radiology Case Reports, 2023
A 44-year-old man with chronic idiopathic pseudo-intestinal obstruction and lumbar disc herniation presented with orthostatic dizziness, black vomiting, and stools.
Sakiko Hiraki, MD, Fumie Sato, MD, Ichiro Okada, MD, Masaya Osugi, MD, Yoshiya Watanabe, MD, Yoshiaki Ichinose, MD   +5 more
doaj   +1 more source

Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach.

PLoS ONE, 2020
Imipenem/cilastatin/relebactam is a β-lactam/β-lactamase inhibitor that has been recently FDA approved for complicated intra-abdominal and urinary tract infections under the brand name Recarbrio®.
Islam M Ghazi, Wasim S El Nekidy, Regan Asay, Paul Fimognari, Anthony Knarr, Mina Awad   +5 more
doaj   +1 more source

Mortality after broad‐ versus narrow‐spectrum antibiotic treatment for patients with nursing and healthcare‐associated pneumonia: A nationwide retrospective cohort study

Journal of Hospital Medicine, EarlyView.
Abstract Background Nursing and healthcare‐associated pneumonia (NHCAP) is defined as pneumonia occurring in individuals with frequent healthcare contact, such as residents of care facilities or patients with impaired activities of daily living. The effectiveness of broad‐spectrum antibiotics in treating NHCAP remains unclear.
Jumpei Taniguchi, Shotaro Aso, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga   +4 more
wiley   +1 more source

Development of a Short-Term Embolic Agent Based on Cilastatin for Articular Microvessels

Medicina
Background and Objectives: This study aimed to develop an embolic agent with short-term embolic effects using cilastatin as the basic material. Materials and Methods: The particle size distribution of 25 mg cilastatin-based short-term embolic agents was ...
Hyun Jin Kim, Areum Jeon, Eun Kyung Kang, Wen An, So Jung Lim, Kyu Chul Shin, Dong Hun Shin, Inyoung Hwang, Ju Seop Kang   +8 more
doaj   +1 more source